Adjuvant Pertuzumab and Trastuzumab in EarlyHuman Epidermal Growth Factor Receptor 2-PositiveBreast Cancer in the APHINITY Trial: Third InterimOverall Survival Analysis With Efficacy Update
08.01.2025
Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Versus Cetuximab as Maintenance Therapy in First-Line Therapy for RAS and BRAF Wild-Type Metastatic Colorectal Cancer: Phase III ERMES Study
07.01.2025
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study
06.01.2025
Determina AIFA - Linea guida di semplificazione delle sperimentazioni cliniche
16.09.2024
21 luglio 2024: Quinta Camminata benefica in ricordo di Daniela Gualtieri
21.07.2024
Trekking da Capriglio
21 luglio 2024
